Search Results

There are 10648 results for: content related to: A Double-Blind, Randomized, Placebo-Controlled Study of Pimobendan in Dogs with Dilated Cardiomyopathy

  1. Pimobendan

    Cardiovascular Drug Reviews

    Volume 6, Issue 4, December 1988, Pages: 265–291, Jan M. Kitzen and Martin M. Winbury

    Version of Record online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1988.tb00380.x

  2. A review of the pharmacology and clinical uses of pimobendan.

    Journal of Veterinary Emergency and Critical Care

    Volume 22, Issue 4, August 2012, Pages: 398–408, Kimberly L. Boyle and Elizabeth Leech

    Version of Record online : 28 AUG 2012, DOI: 10.1111/j.1476-4431.2012.00768.x

  3. Calcium-Sensitizing Drugs: Positive Inotropy by Enhanced Sensitivity of the Contractile Apparatus to Calcium

    Cardiovascular Drug Reviews

    Volume 14, Issue 2, June 1996, Pages: 185–212, L. Ver Donck

    Version of Record online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1996.tb00226.x

  4. EMD 57033: A Novel Ca2+ Sensitizing Agent

    Cardiovascular Drug Reviews

    Volume 14, Issue 4, December 1996, Pages: 334–350, J. D. Schipke and B. Korbmacher

    Version of Record online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1996.tb00317.x

  5. You have free access to this content
    Pharmacology of SCH00013: A Novel Ca2+ Sensitizer

    Cardiovascular Drug Reviews

    Volume 19, Issue 4, December 2001, Pages: 345–368, Masao Endoh, Hiromi Sugawara and Masahiro Mineshima

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2001.tb00075.x

  6. Phosphodiesterase III inhibitors for heart failure

    Intervention Review

    The Cochrane Library

    Emmanuel Amsallem, Christelle Kasparian, G Haddour, Jean-Pierre Boissel and Patrice Nony

    Published Online : 24 JAN 2005, DOI: 10.1002/14651858.CD002230.pub2

  7. You have full text access to this Open Access content
    Effect of Pimobendan on Case Fatality Rate in Doberman Pinschers with Congestive Heart Failure Caused by Dilated Cardiomyopathy

    Journal of Veterinary Internal Medicine

    Volume 22, Issue 4, July–August 2008, Pages: 897–904, M.R. O'Grady, S.L. Minors, M.L. O'Sullivan and R. Horne

    Version of Record online : 4 JUN 2008, DOI: 10.1111/j.1939-1676.2008.0116.x

  8. Cardiovascular effects of pimobendan in healthy mature horses

    Equine Veterinary Journal

    Volume 48, Issue 3, May 2016, Pages: 352–356, T. Afonso, S. Giguère, G. Rapoport, M. H. Barton and A. E. Coleman

    Version of Record online : 4 MAY 2015, DOI: 10.1111/evj.12432

  9. Pharmacology of Levosimendan: A New Myofilament Calcium Sensitizer

    Cardiovascular Drug Reviews

    Volume 14, Issue 3, September 1996, Pages: 286–316, Paul S. Pagel, Heimo Haikala, Pertti J. Pentikäinen, Marja-Leena Toivonen, Markku S. Nieminen, Lasse Lehtonen, Julian Gy. Papp and David C. Warltier

    Version of Record online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1996.tb00232.x

  10. You have free access to this content
    Stage-dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure

    British Journal of Pharmacology

    Volume 172, Issue 9, May 2015, Pages: 2369–2382, Miki Nonaka, Sachio Morimoto, Takashi Murayama, Nagomi Kurebayashi, Lei Li, Yuan-Yuan Wang, Masaki Arioka, Tatsuya Yoshihara, Fumi Takahashi-Yanaga and Toshiyuki Sasaguri

    Version of Record online : 17 MAR 2015, DOI: 10.1111/bph.13062

  11. You have free access to this content
    Pharmacokinetics and cardiovascular effects following a single oral administration of a nonaqueous pimobendan solution in healthy dogs

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 39, Issue 1, February 2016, Pages: 45–53, M. Yata, A. J. McLachlan, D. J. R. Foster, S. W. Page and N. J. Beijerink

    Version of Record online : 21 MAY 2015, DOI: 10.1111/jvp.12243

  12. You have free access to this content
    Contribution of phosphodiesterase isozymes to the regulation of the L-type calcium current in human cardiac myocytes

    British Journal of Pharmacology

    Volume 121, Issue 8, August 1997, Pages: 1549–1556, Katsuya Kajimoto, Nobuhisa Hagiwara, Hiroshi Kasanuki and Saichi Hosoda

    Version of Record online : 11 FEB 2009, DOI: 10.1038/sj.bjp.0701297

  13. Org 30029: A New Cardiotonic Agent Possessing Both Phosphodiesterase Inhibitory and Calcium-Sensitising Properties

    Cardiovascular Drug Reviews

    Volume 8, Issue 3, September 1990, Pages: 179–202, Jean Cottney, Robert Logan, Richard Marshall, David Nicholson, Mohammed Shahid and Glenn Walker

    Version of Record online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1990.tb00392.x

  14. You have free access to this content
    The pharmacokinetics of pimobendan enantiomers after oral and intravenous administration of racemate pimobendan formulations in healthy dogs

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 39, Issue 1, February 2016, Pages: 54–61, E. T. Bell, J. L. Devi, S. Chiu, P. Zahra and T. Whittem

    Version of Record online : 18 MAY 2015, DOI: 10.1111/jvp.12235

  15. You have free access to this content
    Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs

    British Journal of Pharmacology

    Volume 119, Issue 3, October 1996, Pages: 609–615, Paul S. Pagel, Douglas A. Hettrick and David C. Warltier

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1996.tb15716.x

  16. CARDIAC ADRENORECEPTORS

    Journal of Autonomic Pharmacology

    Volume 2, Issue 2, June 1982, Pages: 119–145, K. J. BROADLEY

    Version of Record online : 21 JAN 2008, DOI: 10.1111/j.1474-8673.1982.tb00477.x

  17. You have free access to this content
    Beneficial effects of the Ca2+ sensitizer EMD 57033 in exercising pigs with infarction-induced chronic left ventricular dysfunction

    British Journal of Pharmacology

    Volume 134, Issue 3, October 2001, Pages: 553–562, D J Duncker, D B Haitsma, D A Liem, N Heins, R Stubenitsky and P D Verdouw

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0704292

  18. Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, 1994: NEW DRUGS IN THE TREATMENT OF HEART FAILURE

    Clinical and Experimental Pharmacology and Physiology

    Volume 22, Issue 11, November 1995, Pages: 829–832, Lindsay Brown

    Version of Record online : 28 JUN 2007, DOI: 10.1111/j.1440-1681.1995.tb01944.x

  19. Functions of myocardial α-adrenoceptors

    Journal of Autonomic Pharmacology

    Volume 13, Issue 5, October 1993, Pages: 351–372, B. G. Benfey

    Version of Record online : 21 JAN 2008, DOI: 10.1111/j.1474-8673.1993.tb00283.x

  20. You have free access to this content
    MCI-154: A Second Generation Ca2+ Sensitizer That Does Not Impair Relaxation — A Novel Approach to the Treatment of Heart Failure

    Cardiovascular Drug Reviews

    Volume 18, Issue 4, December 2000, Pages: 271–283, Yoshimi Kitada

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2000.tb00052.x